Cargando…

Young Women with Breast Cancer: Chemotherapy or Surgery First? An Evaluation of Time to Treatment for Invasive Breast Cancer

BACKGROUND: Breast cancer in young women (ages 18–40 years) is rare, yet remains a leading cause of cancer-related death. Time to treatment (TTT) is an increasingly important factor in breast cancer outcomes, specifically time to systemic therapy. Our objective was to review patterns of care for you...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guay, Evelyne, Cordeiro, Erin, Roberts, Amanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Breast Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625669/ https://www.ncbi.nlm.nih.gov/pubmed/34837134 http://dx.doi.org/10.1245/s10434-021-11102-x

Ejemplares similares

Expanded Gene Panel Use for Women With Breast Cancer: Identification and Intervention Beyond Breast Cancer Risk
por: O’Leary, Erin, et al.
Publicado: (2017)

Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer
por: Truin, W., et al.
Publicado: (2015)

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy
por: Straver, M. E., et al.
Publicado: (2010)

Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma
por: Hills, Natalie, et al.
Publicado: (2021)

Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment
por: Ramalingam, Kirithiga, et al.
Publicado: (2023)

Preoperative Delays in the Treatment of DCIS and the Associated Incidence of Invasive Breast Cancer
por: Ward, William H., et al.
Publicado: (2019)

Magnetic Resonance Imaging Evaluation of Noninflammatory Breast Cancer with Skin Involvement After Neoadjuvant Chemotherapy
por: Chen, Jeon-Hor, et al.
Publicado: (2010)

Predictive Value of Neutrophil/Lymphocyte Ratio for Efficacy of Preoperative Chemotherapy in Triple-Negative Breast Cancer
por: Asano, Yuka, et al.
Publicado: (2015)

Impact of Surgical Margins in Breast Cancer After Preoperative Systemic Chemotherapy on Local Recurrence and Survival
por: Wimmer, K., et al.
Publicado: (2019)

Changes in Management Strategy and Impact of Neoadjuvant Therapy on Extent of Surgery in Invasive Lobular Carcinoma of the Breast: Analysis of the National Cancer Database (NCDB)
por: Mukhtar, Rita A., et al.
Publicado: (2021)

Feasibility Study of a Novel Protease-Activated Fluorescent Imaging System for Real-Time, Intraoperative Detection of Residual Breast Cancer in Breast Conserving Surgery
por: Smith, Barbara L., et al.
Publicado: (2020)

Factors Associated with Reoperation in Breast-Conserving Surgery for Cancer: A Prospective Study of American Society of Breast Surgeon Members
por: Landercasper, Jeffrey, et al.
Publicado: (2019)

Progress and Persistent Challenges in Improving Care for Low-Income Women with Breast Cancer
por: Cobb, Adrienne N., et al.
Publicado: (2022)

Chemoprevention for Breast Cancer
por: Pruthi, Sandhya, et al.
Publicado: (2015)

Economic potential of abbreviated breast MRI for screening women with dense breast tissue for breast cancer
por: Tollens, Fabian, et al.
Publicado: (2022)

Survival Nomogram for Young Breast Cancer Patients Based on the SEER Database and an External Validation Cohort
por: Huang, Xiao, et al.
Publicado: (2022)

Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study
por: Fitzal, Florian, et al.
Publicado: (2021)

Fewer Reoperations After Lumpectomy for Breast Cancer with Neoadjuvant Rather than Adjuvant Chemotherapy: A Report from the National Cancer Database
por: Landercasper, Jeffrey, et al.
Publicado: (2017)

The Changing Role of Gene-Expression Profiling in the Era of De-escalating Adjuvant Chemotherapy in Early-Stage Breast Cancer
por: van Steenhoven, J. E. C., et al.
Publicado: (2019)

Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI)
por: Mann, Ritse M., et al.
Publicado: (2022)

Breast density and the likelihood of malignant MRI-detected lesions in women diagnosed with breast cancer
por: Sassi, Antti, et al.
Publicado: (2023)

Timeliness of Breast Diagnostic Imaging and Biopsy in Practice: 15 Years of Collecting, Comparing, and Defining Quality Breast Cancer Care
por: Donovan, Cory Amanda, et al.
Publicado: (2023)

Hormone Treatment without Surgery for Patients Aged 75 Years or Older with Operable Breast Cancer
por: Wink, C. J., et al.
Publicado: (2011)

How Does the Interval Between Completion of Adjuvant Chemotherapy and Initiation of Radiotherapy Impact Clinical Outcomes in Operable Breast Cancer Patients?
por: Cao, Lu, et al.
Publicado: (2020)

Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor-Positive Breast Cancer Patients: Pathologic and Surgical Outcomes
por: Cao, Lifen, et al.
Publicado: (2021)

Disparities in Time to Treatment for Breast Cancer: Shifting Focus to the Root Cause
por: Bayard, Solange, et al.
Publicado: (2022)

Continued Exploration of Bevacizumab in Breast Cancer
por: Mehta, Rita S., et al.
Publicado: (2009)

Metaplastic Breast Cancer: To Radiate or Not to Radiate?
por: Tseng, Warren H., et al.
Publicado: (2010)

Author Reply: Decision-Making Management of Women with a High Risk of Developing Breast and Ovarian Cancer
por: Heemskerk-Gerritsen, Bernadette, et al.
Publicado: (2008)

Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study
por: van Loevezijn, Ariane A., et al.
Publicado: (2020)

A Noninvasive Tool Based on Magnetic Resonance Imaging Radiomics for the Preoperative Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
por: Li, Chenchen, et al.
Publicado: (2022)

Vacuum-Assisted Breast Biopsy After Neoadjuvant Systemic Treatment for Reliable Exclusion of Residual Cancer in Breast Cancer Patients
por: Koelbel, Vivian, et al.
Publicado: (2021)

Mastectomies on the Rise for Breast Cancer: “The Tide Is Changing”
por: Balch, Charles M., et al.
Publicado: (2009)

Access to Surgical Treatment for Breast Cancer in the Philippines
por: Co, Luis Miguel B., et al.
Publicado: (2022)

Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons
por: Manahan, Eric R., et al.
Publicado: (2019)

The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to Have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy
por: Blumencranz, Peter, et al.
Publicado: (2023)

Magnetic resonance imaging system for intraoperative margin assessment for DCIS and invasive breast cancer using the ClearSight™ system in breast‐conserving surgery—Results from a postmarketing study
por: Thill, Marc, et al.
Publicado: (2021)

Long-Term Outcome of Neoadjuvant Endocrine Therapy with Aromatase Inhibitors in Elderly Women with Hormone Receptor-Positive Breast Cancer
por: Grassadonia, Antonino, et al.
Publicado: (2014)

Meta-analysis Comparing Fluorescence Imaging with Radioisotope and Blue Dye-Guided Sentinel Node Identification for Breast Cancer Surgery
por: Kedrzycki, Martha S., et al.
Publicado: (2020)

Three-Dimensional Breast Radiotherapy and the Elective Radiation Dose at the Sentinel Lymph Node Site in Breast Cancer
por: van Roozendaal, Lori M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9nhs0ogkltte7niccc2kj1st1i